Cheng Ke-Yun, Wang Si-Wei, Lan Tian, Mao Zhu-Jun, Xu You-Yao, Shen Qing, Zeng Xi-Xi
Panvascular Diseases Research Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Front Cardiovasc Med. 2024 Nov 26;11:1411621. doi: 10.3389/fcvm.2024.1411621. eCollection 2024.
Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism. CVDs are often referred to as the leading cause of mortality worldwide. Recent advancements in deep sequencing have unveiled a plethora of noncoding RNA transcripts, including circular RNAs (circRNAs), which play pivotal roles in the regulation of CVDs. A decade of research has differentiated various circRNAs by their vasculoprotective or deleterious functions, revealing potential therapeutic targets. This review provides an overview of circRNAs and a comprehensive examination of CVDs, the regulatory circRNAs within the vasculature, and the burgeoning research domain dedicated to these noncoding RNAs.
心血管疾病(CVDs)包括一系列影响心脏和血管的病症,如冠心病、脑血管疾病(如中风)、外周动脉疾病、先天性心脏异常、深静脉血栓形成和肺栓塞。心血管疾病通常被认为是全球范围内主要的死亡原因。深度测序技术的最新进展揭示了大量非编码RNA转录本,包括环状RNA(circRNAs),它们在心血管疾病的调控中发挥着关键作用。十年的研究通过其血管保护或有害功能区分了各种环状RNA,揭示了潜在的治疗靶点。本综述概述了环状RNA,并对心血管疾病、血管系统内的调控性环状RNA以及致力于这些非编码RNA的新兴研究领域进行了全面考察。